Cara Therapeutics, Inc. (CARA) by event type
CARA moves most on analyst downgrades — a median of -9.72% at 30 minutes across 14 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the CARA overview →
How CARA reacts across 3 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades 2,596 of 2,603 | 14 | -9.72% | 14% | -10.60% |
| Coverage initiations 556 of 2,283 | 30 | +0.32% | 63% | +1.47% |
| Rating reiterations 3,353 of 3,522 | 19 | -0.61% | 47% | -0.91% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how CARA usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst downgrades → · Coverage initiations → · Rating reiterations → · CARA overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Patterson Companies, Inc. (PDCO) | 144 | 0.00% | 48% |
| Propanc Biopharma, Inc. (PPCB) | 144 | 0.00% | 41% |
| Nutriband Inc. (NTRB) | 143 | 0.00% | 44% |
| Redhill Biopharma Ltd. - American Depositary Shares (RDHL) | 143 | -0.50% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.